E B Lamont1, M Siegler. 1. Section of the Hematology/Oncology, Robert Wood Johnson Clinical Scholars' Program, The University of Chicago, Chicago, Illinois, USA. elamont@medicine.bsd.uchicago.edu
Abstract
PURPOSE: To determine the frequency of advance care planning (ACP) in hospitalized cancer patients and to assess their reactions to a proposed policy in which medical housestaff would offer to discuss ACP at the time of hospital admission. METHODS: Structured interviews with 111 consecutively admitted cancer patients on the oncology inpatient service of a tertiary care medical center. RESULTS: We found that 69% (77/111) of patients had discussed their advance care preferences with someone, usually a family member, and 33% (37/111) had completed at least one formal advance directive (e.g., a living will or durable power of attorney for health care); 32% (36/111) had done both; and 30% (33/111) had done neither. However, only 9% (10/111) of patients reported having discussed their advance care preferences with their clinic oncologists and only 23% (23/101) of the remaining patients stated that they wished to do so. By contrast, 58% (64/110) of patients supported a policy in which medical housestaff would offer to discuss these advance care preferences as a part of the admission history. CONCLUSIONS: Our data suggest that while oncology inpatients frequently have ACPs that they discuss with family and/or document in formal advance directives, they rarely discuss or wish to discuss these ACPs with clinic oncologists. We also show that most of the reticent patients would nevertheless consider discussing the same ACPs with admitting housestaff on the day of hospital admission.
PURPOSE: To determine the frequency of advance care planning (ACP) in hospitalized cancerpatients and to assess their reactions to a proposed policy in which medical housestaff would offer to discuss ACP at the time of hospital admission. METHODS: Structured interviews with 111 consecutively admitted cancerpatients on the oncology inpatient service of a tertiary care medical center. RESULTS: We found that 69% (77/111) of patients had discussed their advance care preferences with someone, usually a family member, and 33% (37/111) had completed at least one formal advance directive (e.g., a living will or durable power of attorney for health care); 32% (36/111) had done both; and 30% (33/111) had done neither. However, only 9% (10/111) of patients reported having discussed their advance care preferences with their clinic oncologists and only 23% (23/101) of the remaining patients stated that they wished to do so. By contrast, 58% (64/110) of patients supported a policy in which medical housestaff would offer to discuss these advance care preferences as a part of the admission history. CONCLUSIONS: Our data suggest that while oncology inpatients frequently have ACPs that they discuss with family and/or document in formal advance directives, they rarely discuss or wish to discuss these ACPs with clinic oncologists. We also show that most of the reticent patients would nevertheless consider discussing the same ACPs with admitting housestaff on the day of hospital admission.
Authors: Jeremy DeMartini; Joshua J Fenton; Ronald Epstein; Paul Duberstein; Camille Cipri; Daniel Tancredi; Guibo Xing; Paul Kaesberg; Richard L Kravitz Journal: J Pain Symptom Manage Date: 2018-09-25 Impact factor: 3.612
Authors: Judith M Resick; Robert M Arnold; Rebecca L Sudore; David Farrell; Shane Belin; Andrew D Althouse; Betty Ferrell; Bernard J Hammes; Edward Chu; Douglas B White; Kimberly J Rak; Yael Schenker Journal: Contemp Clin Trials Date: 2020-07-31 Impact factor: 2.226
Authors: Natasha Michael; Clare O'Callaghan; Josephine Clayton; Annabel Pollard; Nikola Stepanov; Odette Spruyt; Michael Michael; David Ball Journal: Support Care Cancer Date: 2013-03-14 Impact factor: 3.603